Girard N, Han JY, Soo RA, Wang K, et al. Comparative effectiveness and safety of tislelizumab versus other anti-PD-(L)1 agents in first- and subsequent lines in locally advanced or metastatic non-small cell lung cancer: Systematic literature review and network meta-analysis. Lung Cancer 2025;201:108450.
PMID: 39986214